Comparison of the Effectiveness of Face to Face Rehabilitation and Telerehabilitation in Infants With Congenital Muscular Torticollis

April 25, 2025 updated by: Gökçen Erol, Istanbul University - Cerrahpasa

Who is this study for? This study is designed for infants aged 0-6 months who have been diagnosed with Congenital Muscular Torticollis (CMT). CMT is a condition observed at birth or shortly after, characterized by the shortening of the sternocleidomastoid (SCM) muscle, leading to the baby's head tilting to one side and rotating to the opposite side. It affects both boys and girls and may result in limited neck movement, abnormal posture, facial asymmetry, and potential developmental delays if left untreated.

What is the purpose of this study? The goal of this study is to compare the effectiveness of two different physical therapy methods-face-to-face rehabilitation and telerehabilitation-in treating infants with CMT. In addition to evaluating the outcomes of these two therapy methods, this research also aims to provide families with reliable, accessible information through a web-based educational platform.

Why is this study important? Early diagnosis and intervention are crucial for optimal recovery in infants with CMT. Studies show that infants who begin therapy by one month of age have up to a 98% chance of full recovery. However, if diagnosis and treatment are delayed, the recovery process can take longer and may be less effective. This study will help determine if online (telerehabilitation) sessions can be just as effective as traditional face-to-face therapy, offering a flexible and accessible treatment option for families.

What are the benefits of participating?

  • Access to a structured, evidence-based rehabilitation program for your child
  • Guidance from trained pediatric physiotherapists
  • Increased awareness and knowledge about CMT through a web-based family education platform
  • Contribution to research that may benefit other children and families in the future
  • Evaluation of your baby's progress through professional assessments

What will the therapy program involve?

Participants will be randomly assigned to either a face-to-face or telerehabilitation group. Both groups will follow the same therapy program, focusing on:

  • Increasing passive and active neck movements
  • Promoting symmetrical head and body movement
  • Providing recommendations for environmental adjustments
  • Educating parents or caregivers on home-based exercises and care

Program structure:

  • Face-to-face group: Therapy sessions will be conducted in a clinic setting, twice a week for 30 minutes each session, over a period of 8 weeks.
  • Telerehabilitation group: Therapy sessions will be conducted via Zoom, with the same frequency, duration, and content as the face-to-face sessions.

How will outcomes be measured?

Infants will be assessed before and after the 8-week therapy period for:

  • Passive cervical range of motion (rotation and lateral flexion)
  • Gross motor function
  • Muscle function Parental adherence to the home program will also be evaluated through a questionnaire. A follow-up will be conducted one month after therapy ends.

How can I participate? If your infant is aged 0-6 months and has been diagnosed with CMT, you may be eligible to participate. You will need access to a device with internet for telerehabilitation sessions, if assigned to that group. Participation is voluntary and free of charge. Families will receive detailed instructions and ongoing support throughout the program.

Additional Resources:

As part of this study, a web-based educational platform will be made available to all participating families. This platform will include:

  • Clear explanations about CMT
  • Instructional videos and home exercise guides
  • Tips for daily care and positioning
  • Frequently asked questions (FAQ) for parents Why is this research unique? This is one of the first studies to scientifically compare face-to-face and online rehabilitation for CMT infants, while also providing a reliable online resource for families. It aims to help develop alternative, flexible care models that meet the diverse needs of families and infants.

Contact Information:

If you are interested in participating or would like more information, please contact our research team at:

[fgokcenalaca@gmail.com / +905534646606] We are committed to supporting your child's health and development. Thank you for considering being a part of this important study.

Study Overview

Detailed Description

Study Design This study is designed as a prospective, randomized controlled clinical trial to compare the effectiveness of face-to-face and telerehabilitation programs in infants diagnosed with Congenital Muscular Torticollis (CMT) between 0-6 months of age. Both groups will receive an identical intervention protocol, consisting of two sessions per week, 30 minutes each, over a total of 8 weeks.

The intervention content includes exercises to increase active cervical range of motion (ROM), activities promoting symmetrical movements, family education, home exercise programs, and practices to support gross motor development.

Study Population and Sample Size In a study by Lee et al. (2015), the effect size for head tilt angle was calculated as 1.45. Based on this effect size, with α = 0.05 and a power of 99%, the required sample size was determined to be 19 participants per group. With an anticipated 15% drop-out rate, the total sample size was set at 42 infants.

Inclusion Criteria

  • Diagnosed with Congenital Muscular Torticollis (CMT)
  • Infants under 6 months of age
  • Classified as level 1 to 3 according to the CMT classification system

Exclusion Criteria

  • Presence of ocular torticollis
  • Neurological complications (e.g., cerebral palsy)
  • Congenital anomalies of the cervical spine or spinal cord
  • Visual or auditory impairments

Participant Recruitment and Randomization Infants referred with a diagnosis of CMT will be screened, and those who meet the inclusion criteria will be invited to participate. Families will be informed in detail, and written informed consent will be obtained. Participants will be randomly allocated into two groups (face-to-face and telerehabilitation) using computer-generated simple randomization (n = 21 per group).

Outcome Measures

All outcomes will be assessed at baseline and after the 8-week intervention period:

  • Passive cervical range of motion (ROM): Measured using a goniometer
  • Alberta Infant Motor Scale (AIMS): To evaluate gross motor development
  • Head tilt angle: Assessed using a standardized photographic measurement protocol
  • Muscle Function Scale: To assess the functional status of neck muscles
  • Adherence to home exercise program: Evaluated through a parent-reported checklist

Statistical Analysis Data will be analyzed using SPSS version 26.0 (IBM Corp, Armonk, NY). Descriptive statistics (mean, standard deviation, frequency, percentage) will be presented for both categorical and continuous variables. The Levene test will be used to assess homogeneity of variances. For between-group comparisons, independent-samples t-test will be used for normally distributed data; otherwise, the Mann-Whitney U test will be applied. A p-value < 0.05 will be considered statistically significant.

Research Hypotheses H₀: There is no significant difference between telerehabilitation and face-to-face rehabilitation in infants with CMT in terms of cervical ROM, gross motor function, muscle function, and parental adherence.

H₁: There is a significant difference between telerehabilitation and face-to-face rehabilitation in infants with CMT in terms of cervical ROM, gross motor function, muscle function, and parental adherence.

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Istanbul, Turkey, 34500
        • Istanbul University - Cerrahpasa, Faculty of Health Sciences, Büyükçekmece Campus, Alkent 2000 Mah. Yiğittürk Street No:5/9/1, Büyükçekmece/Istanbul, Turkey
        • Contact:
        • Contact:
        • Principal Investigator:
          • GÖKÇEN EROL

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Infants aged 0 to 6 months
  • Diagnosed with congenital muscular torticollis (CMT)
  • Classified as Grade 1 to 3 CMT severity based on clinical assessment

Exclusion Criteria:

  • Plagiocephaly
  • Ocular torticollis
  • Neurological complications
  • Musculoskeletal disorders of the cervical spine
  • Visual impairments
  • Hearing impairments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telerehabilitation

The telerehabilitation group receives the same structured, neurodevelopmentally-based rehabilitation program as the face-to-face group. However, the delivery method-via online video conferencing (Zoom)-represents a novel mode of application for this specific intervention in infants with congenital muscular torticollis (CMT).

To date, this therapeutic program has not been delivered through telehealth for this population, and its feasibility, effectiveness, and comparability to the conventional face-to-face method have not yet been studied. Therefore, this arm is considered experimental as it involves a new and previously untested method of intervention delivery, even though the therapeutic content remains the same.

The telerehabilitation program provides the same therapeutic content as the face-to-face rehabilitation group but will be delivered remotely via the Zoom video conferencing platform. The program will be applied to infants aged 0-6 months with congenital muscular torticollis (CMT) and is based on neurodevelopmental treatment (NDT) principles, including:

Passive range of motion (ROM) exercises for the neck

Active ROM exercises for the neck and trunk

Activities for symmetrical movement development

Environmental modification suggestions

Parent/caregiver education and guidance

Sessions will be conducted via live video calls, twice per week, 30 minutes per session, for 8 weeks.

Each family will also receive an individualized home exercise program, with its frequency and duration adapted to the infant's needs.

Active Comparator: Face to face rehabilitation

The face-to-face rehabilitation group receives a structured, neurodevelopmental treatment program that is already in routine clinical use for infants with congenital muscular torticollis (CMT). It represents the current standard method of delivering this intervention in clinical settings.

Since the objective of the study is to compare the effectiveness of a novel telerehabilitation delivery model against this established, routinely used face-to-face method, the face-to-face arm serves as the active comparator. This arm provides a baseline for evaluating the outcomes of the experimental telerehabilitation approach.

The face-to-face rehabilitation program will be delivered in a clinical setting to infants aged 0-6 months with congenital muscular torticollis (CMT). It is based on neurodevelopmental treatment (NDT) principles and consists of:

Passive range of motion (ROM) exercises for the neck

Active ROM exercises for the neck and trunk

Activities to promote the development of symmetrical movement

Environmental modification suggestions for the home setting

Parent/caregiver education and training

Sessions will be conducted twice per week, 30 minutes per session, over a total of 8 weeks.

In addition, an individualized home exercise program will be prescribed for each infant based on their specific needs. Frequency and duration of the home exercises may vary accordingly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Passive Cervical Range of Motion (Lateral Flexion and Rotation)
Time Frame: Baseline, Week 8 (post-treatment), and 1-month follow-up

Passive range of motion (ROM) of the neck, specifically lateral flexion and rotation, will be assessed using an arthrodial goniometer. Measurements will be taken at three time points:

Baseline (Pre-intervention) Post-intervention (At the end of 8 weeks of rehabilitation) Follow-up (1 month after the end of the intervention) This outcome aims to evaluate changes in cervical mobility in response to the rehabilitation programs.

Baseline, Week 8 (post-treatment), and 1-month follow-up
Head Tilt Angle (Still Photography Method)
Time Frame: Baseline, Week 8 (post-treatment), and 1-month follow-up

Head tilt will be assessed using the Still Photography Method, a standardized photographic procedure:

A photograph of the infant is taken in a supin position. A horizontal line is drawn connecting the pupils of both eyes (inter-pupillary line).

A second line is drawn connecting the acromion processes of both shoulders. The acute angle between these two lines is measured to quantify the degree of head tilt.

This method allows for an objective and reliable evaluation of head posture asymmetry in infants with congenital muscular torticollis (CMT).

Baseline, Week 8 (post-treatment), and 1-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Function Test (MFT)
Time Frame: Baseline, Week 8 (post-treatment), and 1-month follow-up

The Muscle Function Test (MFT) is a visual assessment tool used to evaluate the infant's head-righting response. The procedure is performed as follows:

The infant is held in a vertical position, facing a mirror.

The infant is then slowly moved into a horizontal position, toward the side of the shortened sternocleidomastoid (SCM) muscle.

The evaluator observes the head and neck righting reaction, focusing on the infant's ability to align the head vertically in response to the positional change.

The test is scored on a 6-point scale (0-5) based on the alignment of the head relative to the vertical axis.

Baseline, Week 8 (post-treatment), and 1-month follow-up
Alberta Infant Motor Scale (AIMS)
Time Frame: Baseline, Week 8 (post-treatment), and 1-month follow-up

The Alberta Infant Motor Scale (AIMS) will be used to assess gross motor development in infants. AIMS is a standardized observational assessment tool designed to evaluate motor performance and monitor the effectiveness of early interventions in infants aged 0 to 18 months.

The test consists of 58 items and takes approximately 10 minutes to administer. The infant's spontaneous movements are observed in four positions: supine, prone, sitting, and standing, without any physical contact.

Each item that the infant successfully performs is scored as 1 point. The total raw score is then converted into a percentile score based on age norms. The percentile rank reflects the infant's motor performance in comparison to age-matched peers.

According to the normative chart:

Percentiles of 5% or below indicate atypical development.

Percentiles below 10% suggest the infant is at risk for motor delay.

Scores are categorized as normal, suspicious, or abnormal.

The AIMS has demonstrated strong va

Baseline, Week 8 (post-treatment), and 1-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nilay Arman, Istanbul University-Cerrahpasa,Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Division of Physiotherapy and Rehabilitation
  • Principal Investigator: GÖKÇEN EROL, Istanbul University-Cerrahpasa, Graduate School of Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 25, 2025

Primary Completion (Estimated)

September 25, 2026

Study Completion (Estimated)

December 25, 2026

Study Registration Dates

First Submitted

April 25, 2025

First Submitted That Met QC Criteria

April 25, 2025

First Posted (Actual)

May 4, 2025

Study Record Updates

Last Update Posted (Actual)

May 4, 2025

Last Update Submitted That Met QC Criteria

April 25, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telerehabilitation

Clinical Trials on telerehabilitation

Subscribe